Viral heparin-binding complement inhibitors--a recurring theme.
Blom
Anna M
AM
Lund University, Department of Laboratory Medicine, The Wallenberg Laboratory, 4th floor, Malmö University Hospital, entrance 46, S-205 02 Malmö, Sweden.
Mark
Linda
L
Spiller
O Brad
OB
D000595:Amino Acid Sequence; D000818:Animals; D003167:Complement Activation; D051056:Complement Inactivating Agents / Q000276:immunology*; D006493:Heparin / Q000378:metabolism*; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D008969:Molecular Sequence Data; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism; D014764:Viral Proteins / Q000276:immunology*; D014780:Viruses / Q000276:immunology*
D051056:Complement Inactivating Agents; D014759:Viral Envelope Proteins; D014764:Viral Proteins; C038535:glycoprotein gC, herpes simplex virus type 1; D006493:Heparin